It was found that tumor weight and volume was higher in the group of mice which received LB-100-treated OT-II Th9 cells as compared to the group of mice which received OT-II-Th9 cells alone (Fig. 6a, b), suggesting that the inhibition of PP2A abrogates the anti-tumor functions of Th9 cells. Here, PTPA is linked to neoplasm.